Medesto

Overview

Medesto Health is an early-stage patient engagement and care coordination platform for specialty therapy workflows. The company formally launched in February 2026 after spinning out from Perigon Health 360 and positions itself between patients, pharmacies, providers, payers, PBMs, and pharmaceutical manufacturers.

For a biopharma launch team, Medesto should be evaluated as a software-led hub-adjacent platform rather than as a scaled outsourced hub services operator. Its company materials are strongest around engagement automation, care-team visibility, adherence support, intervention triggers, and real-world data capture. Buyers should validate which operational steps Medesto performs directly versus which steps remain with the manufacturer, hub vendor, specialty pharmacy, provider, or payer partner.

Hub Capability Model

The framework below standardizes how Rx Almanac evaluates hub-services capabilities, so buyers can compare vendors like-for-like while the readout column stays vendor-specific. For this table, Medesto is evaluated as an early-stage software-led hub-adjacent platform for engagement and care coordination.

Capability	Buyer should compare	Medesto readout
Therapy initiation and enrollment intake	Digital and human intake, eConsent, missing-information resolution, provider/patient portals, and clean case creation.	Documented platform adjacency. Public materials support intake, consent, and patient-facing coordination workflows, but buyers should confirm whether Medesto staffs enrollment operations or supplies software to another operator.
Benefits verification and coverage triage	Medical/pharmacy benefit verification, eligibility checks, payer-policy lookup, coverage routing, and speed from referral to actionable case.	Validate in diligence. Existing wiki materials describe PA and benefits workflow support, but the public launch materials emphasize engagement and care coordination more than full reimbursement operations.
Prior authorization, appeals, and reimbursement casework	PA initiation, payer-specific forms, clinical documentation, appeals, denial management, and field reimbursement handoffs.	Validate in diligence. Treat Medesto as a workflow platform until the buyer confirms payer-form execution, appeals staffing, audit trails, and handoffs to field reimbursement or hub teams.
Affordability, PAP, and copay operations	Copay, free-drug, bridge, foundation, income verification, PAP renewal, and gross-to-net sensitive affordability logic.	Adjacent. Positioning includes affordability handoff potential, but Medesto is not a complete copay / PAP operator — pair with a hub for full PAP scope.
Patient engagement and adherence operations	Omnichannel reminders, clinical education, nursing or training escalation, persistence outreach, and patient-facing support quality.	Core engagement model. Medesto’s public launch centers on automated patient engagement, adherence visibility, care-team communication, and intervention triggers.
Fulfillment, specialty pharmacy, and distribution coordination	Routing to SPs, non-commercial dispensing, DTP shipment, sample/replacement product, 3PL, and cold-chain handoffs.	Partner-dependent. Specialty pharmacy heritage is relevant, but the public profile should not be read as evidence that Medesto independently operates dispensing, distribution, or 3PL services.
Program reporting, integrations, and governance	Manufacturer dashboards, KPI reporting, CRM/EHR/API integrations, SLA governance, and operating visibility across vendors.	Documented platform claim. Public materials describe real-world data capture and feeds into existing health records; diligence should test integration depth, dashboard design, data rights, and SLA governance.

Buyer Fit

• Use-case fit: Consider Medesto when a launch or specialty-pharmacy program needs a patient engagement and care coordination layer across patient, care-team, and workflow data.
• Therapy and product fit: Current metadata points to Rare Disease; drug-type fit is Specialty, Biologics.
• Commercial fit: Pricing is listed as Subscription, so scope the platform, integrations, service levels, and operating handoffs before comparing it with full-service hub vendors.
• Profile signal: Best-fit buyers include pharma manufacturers, biotech teams, providers, payers, PBMs, and specialty / retail pharmacy operators.
• Network diligence: Confirm whether Medesto provides software only, software plus care-team workflow support, or a staffed service model.

Differentiators

• Perigon Health 360 heritage: Medesto carries forward a pharmacy-connected patient-support lineage rather than starting from a generic CRM or notification tool.
• Patient and care-team coordination: The platform is positioned to connect patients with the care teams responsible for keeping therapy moving.
• Risk and intervention workflow: Medesto emphasizes surfacing urgent issues, triggering interventions, and reducing care-team time spent searching across disconnected systems.
• Data capture and integration angle: Public materials describe patient, medication, assessment, and workflow data capture that can feed existing health records.

RFP Questions

• Which steps are performed by Medesto, by a partner specialty pharmacy, by an outsourced hub, and by the manufacturer?
• How does Medesto provide care-team staffing, or is it a platform for the buyer’s own teams and partners?
• Which EHR, pharmacy-system, CRM, and data-warehouse integrations are production-ready today?
• How are consent, HIPAA controls, audit trails, patient communications, and clinical escalation governed?
• Which time-to-therapy, first-fill, adherence, intervention, and abandonment metrics can be reported at brand level?
• How do affordability, PA, pharmacy routing, and fulfillment handoffs work when another vendor owns those operations?

Recent Activity

• February 2026: Medesto formally launched as an independent patient engagement and care coordination platform after spinning out from Perigon Health 360.
• February 2026: DBusiness covered Medesto as a Livonia-based healthcare technology company focused on patient engagement.
• 2025-2026: Active development of Waste Radar module for medication waste detection and E-Signia for electronic signature/consent management.
• 2013-2025 (as Perigon Health 360): Decade of platform development supporting 350+ healthcare institutions and specialty pharmacy workflows.